DK0808367T3 - Vaskulære slimhindeaddressiner samt anvendelse deraf - Google Patents

Vaskulære slimhindeaddressiner samt anvendelse deraf

Info

Publication number
DK0808367T3
DK0808367T3 DK96906504T DK96906504T DK0808367T3 DK 0808367 T3 DK0808367 T3 DK 0808367T3 DK 96906504 T DK96906504 T DK 96906504T DK 96906504 T DK96906504 T DK 96906504T DK 0808367 T3 DK0808367 T3 DK 0808367T3
Authority
DK
Denmark
Prior art keywords
madcam
primate
recombinant
proteins
relates
Prior art date
Application number
DK96906504T
Other languages
English (en)
Inventor
Michael J Briskin
Douglas J Ringler
Dominic Picarella
Walter Newman
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27011628&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0808367(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/386,857 external-priority patent/US6551593B1/en
Priority claimed from US08/523,004 external-priority patent/US7750137B2/en
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Application granted granted Critical
Publication of DK0808367T3 publication Critical patent/DK0808367T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
DK96906504T 1995-02-10 1996-02-12 Vaskulære slimhindeaddressiner samt anvendelse deraf DK0808367T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/386,857 US6551593B1 (en) 1995-02-10 1995-02-10 Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam
US08/523,004 US7750137B2 (en) 1995-09-01 1995-09-01 Mucosal vascular addressins
PCT/US1996/002153 WO1996024673A1 (en) 1995-02-10 1996-02-12 Mucosal vascular addressins and uses thereof

Publications (1)

Publication Number Publication Date
DK0808367T3 true DK0808367T3 (da) 2007-11-05

Family

ID=27011628

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96906504T DK0808367T3 (da) 1995-02-10 1996-02-12 Vaskulære slimhindeaddressiner samt anvendelse deraf

Country Status (12)

Country Link
EP (1) EP0808367B1 (da)
JP (1) JP4205162B2 (da)
AT (1) ATE366809T1 (da)
AU (1) AU4986296A (da)
CA (1) CA2212702C (da)
DE (1) DE69637155T2 (da)
DK (1) DK0808367T3 (da)
ES (1) ES2290955T3 (da)
MX (1) MX9706049A (da)
NZ (1) NZ303523A (da)
PT (1) PT808367E (da)
WO (1) WO1996024673A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0948597A4 (en) * 1996-11-01 2002-07-10 Human Genome Sciences Inc Human, mucous membrane-specific addressin cell adhesion molecule (MAdCAM-1) and its splice variants
AU7348798A (en) * 1997-05-09 1998-12-08 John P. Robarts Research Institute, The Method for dislodging infiltrated leukocytes from a tissue
AU2007201698B2 (en) * 1998-05-13 2011-10-13 Genentech, Inc. Diagnosis and treatment of hepatic disorders
US7090845B2 (en) 1998-05-13 2006-08-15 Genentech, Inc. Diagnosis and treatment of hepatic disorders
CA2330000C (en) * 1998-05-13 2015-06-23 Genentech, Inc. Diagnosis and treatment of hepatic disorders
AUPR524101A0 (en) 2001-05-25 2001-06-21 Council Of The Queensland Institute Of Medical Research, The Antigen targeting
WO2003047526A2 (en) * 2001-11-30 2003-06-12 Incyte Genomics, Inc. Cell adhesion and extracellular matrix proteins
WO2004081049A1 (en) * 2003-03-10 2004-09-23 Auckland Uniservices Limited Monoclonal antibodies that recognise mucosal addressin cell adhesion molecule-1 (madcam-1), soluble madcam-1 and uses thereof
JP4613300B2 (ja) 2003-05-01 2011-01-12 ザ スクリプス リサーチ インスティチュート 選択的ｒ−カドヘリンアンタゴニストおよび方法
JP4315982B2 (ja) 2004-01-09 2009-08-19 ファイザー インコーポレイティッド ＭＡｄＣＡＭに対する抗体
RU2453558C2 (ru) 2004-09-03 2012-06-20 Дженентек, Инк. Гуманизированные антагонистические антитела против бета7 и их применение
EP1904531B1 (en) * 2005-07-08 2010-10-06 Pfizer Limited Madcam antibodies
WO2007007152A2 (en) * 2005-07-11 2007-01-18 Pfizer Limited Anti-madcam antibodies to treat metastatic cancers and chloroma
EP2279004B1 (en) * 2008-05-16 2015-01-14 F. Hoffmann-La Roche AG Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7integrin antagonists
UA116189C2 (uk) 2011-05-02 2018-02-26 Мілленніум Фармасьютікалз, Інк. КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
CN108969469A (zh) 2011-05-02 2018-12-11 米伦纽姆医药公司 抗α4β7抗体的制剂
JP2017537105A (ja) 2014-11-26 2017-12-14 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 瘻孔を伴うクローン病の治療用ベドリズマブ
JP6904905B2 (ja) 2014-12-24 2021-07-21 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 抗α４β７インテグリン抗体による治療の結果の予測
MA41636A (fr) 2015-03-06 2018-01-09 Millennium Pharm Inc Méthode de traitement de la cholangite sclérosante primitive
US20200002422A1 (en) 2016-03-14 2020-01-02 Millennium Pharmaceuticals, Inc. Method of preventing graft versus host disease
CN109153721A (zh) 2016-03-14 2019-01-04 千禧制药公司 治疗或预防移植物抗宿主疾病的方法
TW201735949A (zh) 2016-03-24 2017-10-16 千禧製藥公司 治療抗ctla4及抗pd-1組合治療中的胃腸道免疫相關不良事件之方法
EP3433275A1 (en) 2016-03-24 2019-01-30 Millennium Pharmaceuticals, Inc. Methods of treating gastrointestinal immune-related adverse events in immune oncology treatments
MA44864A (fr) 2016-05-04 2019-03-13 Icahn School Med Mount Sinai Trithérapie pour le traitement d'une maladie intestinale inflammatoire
MA45245A (fr) 2016-06-12 2019-04-17 Millennium Pharm Inc Méthode de traitement de maladie intestinale inflammatoire
WO2018104893A1 (en) 2016-12-06 2018-06-14 Glaxosmithkline Intellectual Property Development Limited Alpha4-beta7 antibodies with incrased fcrn binding and/or half-life
KR20190141148A (ko) 2017-04-28 2019-12-23 밀레니엄 파머슈티컬스 인코퍼레이티드 소아 장애를 치료하는 방법
CR20200076A (es) * 2017-07-14 2020-06-10 Pfizer ANTICUERPOS CONTRA MAdCAM
US11739146B2 (en) * 2019-05-20 2023-08-29 Pandion Operations, Inc. MAdCAM targeted immunotolerance

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994013312A1 (en) * 1992-12-15 1994-06-23 The Board Of Trustees Of The Leland Stanford Junior University Mucosal vascular addressin, dna and expression

Also Published As

Publication number Publication date
AU4986296A (en) 1996-08-27
ATE366809T1 (de) 2007-08-15
ES2290955T3 (es) 2008-02-16
PT808367E (pt) 2007-10-22
CA2212702A1 (en) 1996-08-15
EP0808367A1 (en) 1997-11-26
DE69637155T2 (de) 2008-02-07
CA2212702C (en) 2010-04-20
DE69637155D1 (de) 2007-08-23
WO1996024673A1 (en) 1996-08-15
JPH10513365A (ja) 1998-12-22
JP4205162B2 (ja) 2009-01-07
MX9706049A (es) 1998-02-28
EP0808367B1 (en) 2007-07-11
NZ303523A (en) 2002-02-01

Similar Documents

Publication Publication Date Title
DK0808367T3 (da) Vaskulære slimhindeaddressiner samt anvendelse deraf
Geiser et al. The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes
Pearse Receptors compete for adaptors found in plasma membrane coated pits.
Postlethwaite et al. Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment.
Chertov et al. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils
Senger et al. Purification of a human milk protein closely similar to tumor-secreted phosphoproteins and osteopontin
Timpl et al. [47] Laminin
DE60219611T2 (de) Modifizierte annexin-proteine und verhinderung und behandlung von thrombose
US20060173162A1 (en) Bactericidak anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp)
JP2939557B2 (ja) フォン・ウィレブラント因子の５２／４８ｋＤａポリペプチドフラグメントから誘導可能なペプチド
JP2512453B2 (ja) 天然のコロニ−促進因子―１の精製
JP2004043502A (ja) 新規蛋白質及びこれを使用した薬剤の製法
JP2005053921A (ja) 殺菌性／透過性が向上したタンパク質の機能領域に由来する生物学的に活性なペプチドおよびその使用
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
JPH03204896A (ja) インターフェロンレセプター細胞外断片
JP4794102B2 (ja) フィブリンのシトルリン誘導体及び慢性関節リウマチの診断又は治療のためのその使用
WO1994025476A1 (en) Recombinant bpi-based and lbp-based proteins, nucleic acid molecules encoding same, methods of producing same, and uses thereof
EP1683866B1 (en) Deletion forms of IgE-dependent histamine releasing factor having histamine-releasing activity, HRF-binding peptides and the uses thereof
HU226468B1 (en) Amino-terminally truncated mcp-2-as chemokine antagonists
McNaughton et al. Novel anti-inflammatory peptides based on chemokine–glycosaminoglycan interactions reduce leukocyte migration and disease severity in a model of rheumatoid arthritis
EA009414B1 (ru) Терапевтические применения вариантов хемокинов
JP2829405B2 (ja) 機能性ポリペプチド
JPH06503966A (ja) 生合成したｐｄｇｆアンタゴニスト
Bond et al. Native and recombinant Fel dI as probes into the relationship of allergen structure to human IgE immunoreactivity
EP0698666B1 (en) Modified epimorphin